STAGE 1 RESULTS OF A 2-STAGE PHASE II TRIAL OF SINGLE AGENT AMRUBICIN IN PATIENTS WITH PREVIOUSLY TREATED THYMIC MALIGNANCIES

被引：0
|
作者：
Wakelee, Heather A. [1 ]
Riess, Jonathan W. [1 ]
San Pedro-Salcedo, Melanie [1 ]
Padda, Sukhmani K. [1 ]
Ramchandran, Kavitha [1 ]
Gubens, Matthew A. [2 ]
Neal, Joel W. [1 ]
机构：
[1] Stanford Univ, Sch Med, Div Oncol, Stanford, CA 94305 USA
[2] UCSF, Div Hematol & Oncol, San Francisco, CA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
chemotherapy; thymoma; Thymic carcinoma; amrubicin;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.24-048
引用
收藏
页码：S731 / S731
页数：1
相关论文
共 50 条
  • [1] STAGE 1 RESULTS OF A 2-STAGE PHASE II TRIAL OF SINGLE AGENT AMRUBICIN IN PATIENTS WITH PREVIOUSLY TREATED THYMIC MALIGNANCIES
    Wakelee, Heather
    Riess, Jonathan
    Pedro-Salcedo, Melanie San
    Padda, Sukhmani
    Ramchandran, Kavitha
    Gubens, Matthew
    Neal, Joel
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : 22 - 23
  • [2] Phase II trial of single agent amrubicin in patients with previously treated advanced thymic malignancies
    Hellyer, Jessica A.
    Gubens, Matthew A.
    Cunanan, Kristen M.
    Padda, Sukhmani K.
    Burns, Matthew
    Spittler, A. John
    Riess, Jonathan W.
    San Pedro-Salcedo, Melanie
    Ramchandran, Kavitha J.
    Neal, Joel W.
    Wakelee, Heather A.
    Loehrer, Patrick J., Sr.
    LUNG CANCER, 2019, 137 : 71 - 75
  • [3] Phase II Trial of Single Agent Amrubicin in Patients with Previously Treated Advanced Thymic Malignancies
    Wakelee, Heather A.
    Padda, Sukhmani K.
    Burns, Matthew
    Spittler, A. J.
    Riess, Jonathan W.
    San Pedro-Salcedo, Melanie
    Ramchandran, Kavitha J.
    Gubens, Matthew A.
    Neal, Joel W.
    Loehrer, Patrick J.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S195 - S195
  • [4] Amrubicin in previously treated patients with malignant pleural mesothelioma: A phase II study
    Ikeda, Takaya
    Takemoto, Shinnosuke
    Senju, Hiroaki
    Gyotoku, Hiroshi
    Taniguchi, Hirokazu
    Shimada, Midori
    Dotsu, Yosuke
    Umeyama, Yasuhiro
    Tomono, Hiromi
    Kitazaki, Takeshi
    Fukuda, Masaaki
    Soda, Hiroshi
    Yamaguchi, Hiroyuki
    Fukuda, Minoru
    Mukae, Hiroshi
    THORACIC CANCER, 2020, 11 (07) : 1972 - 1978
  • [5] Phase II trial of S-1 treatment as palliative-intent chemotherapy for previously treated advanced thymic carcinoma
    Okuma, Yusuke
    Goto, Yasushi
    Ohyanagi, Fumiyoshi
    Sunami, Kuniko
    Nakahara, Yoshiro
    Kitazono, Satoru
    Kudo, Keita
    Tambo, Yuichi
    Kanda, Shintaro
    Yanagitani, Noriko
    Horiike, Atsushi
    Horinouchi, Hidehito
    Fujiwara, Yutaka
    Nokihara, Hiroshi
    Yamamoto, Noboru
    Nishio, Makoto
    Ohe, Yuichiro
    Hosomi, Yukio
    CANCER MEDICINE, 2020, 9 (20): : 7418 - 7427
  • [6] Phase II Trial of S-1 Treatment as Palliative-Intent Chemotherapy for Previously Treated Advanced Thymic Carcinoma
    Ohyanagi, F.
    Okuma, Y.
    Goto, Y.
    Sunami, K.
    Nakahara, Y.
    Kitazono, S.
    Tambo, Y.
    Yanagitani, N.
    Kanda, S.
    Horiike, A.
    Horinouchi, H.
    Fujiwara, Y.
    Nokihara, H.
    Yamamoto, N.
    Nishio, M.
    Ohe, Y.
    Hosomi, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1868 - S1868
  • [7] A phase II study of amrubicin, a synthetic 9-aminoanthracycline, in patients with previously treated lung cancer
    Kaira, Kyoichi
    Sunaga, Noriaki
    Tomizawa, Yoshio
    Yanagitani, Noriko
    Shimizu, Kimihiro
    Imai, Hisao
    Utsugi, Mitsuyoshi
    Iwasaki, Yasuki
    Iijima, Hironobu
    Tsurumaki, Hiroaki
    Yoshii, Akihiro
    Fueki, Naoto
    Hisada, Takeshi
    Ishizuka, Tamotsu
    Saito, Ryusei
    Mori, Masatomo
    LUNG CANCER, 2010, 69 (01) : 99 - 104
  • [8] Phase II study of amrubicin at a dose of 45 mg/m2 in patients with previously treated small-cell lung cancer
    Asao, Tetsuhiko
    Nokihara, Hiroshi
    Yoh, Kiyotaka
    Niho, Seiji
    Goto, Koichi
    Ohmatsu, Hironobu
    Kubota, Kaoru
    Yamamoto, Noboru
    Sekine, Ikuo
    Kunitoh, Hideo
    Fujiwara, Yutaka
    Ohe, Yuichiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (10) : 941 - 946
  • [9] Phase II Study of Sunitinib in Patients with Thymic Carcinoma Previously Treated with Platinum-Based Chemotherapy (KOSMIC Trial)
    Kim, S. H.
    Kim, Y. J.
    Ock, C.
    Kim, M.
    Keam, B.
    Kim, T. M.
    Kim, D.
    Heo, D. S.
    Lee, J. S.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S346 - S347
  • [10] Phase II study of S-1 in patients with previously-treated invasive thymoma and thymic carcinoma: North Japan lung cancer study group trial 1203
    Tsukita, Yoko
    Inoue, Akira
    Sugawara, Shunichi
    Kuyama, Shoichi
    Nakagawa, Taku
    Harada, Daijiro
    Tanaka, Hisashi
    Watanabe, Kana
    Mori, Yoshiaki
    Harada, Toshiyuki
    Hino, Toshihiko
    Fujii, Masanori
    Ichinose, Masakazu
    LUNG CANCER, 2020, 139 : 89 - 93
12345